23andMe Holding Co. (ME)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Jan 06, 2025

$3.78

P/E Ratio

N/A

Market Cap

$103.32M

Loading...
Description

23andMe Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. It operates through the Consumer and Research Services, and Therapeutics segments. The Consumer and Research Services segment consists of Personal Genome Service, Telehealth Business, and Research Services. The Therapeutics segment focuses on the genetic insights of genetic and phenotypic information. The company was founded by Anne E. Wojcickiin 2006 and is headquartered in Sunnyvale, CA.

Metrics

Overview

  • HQSunnyvale, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerME
  • Price$3.78-0.26%

Trading Information

  • Market cap$103.32M
  • Float8.64%
  • Average Daily Volume (1m)228,197
  • Average Daily Volume (3m)715,032
  • EPS-$25.27

Company

  • Revenue$193.26M
  • Rev growth (1yr)-11.86%
  • Net income-$59.10M
  • Gross margin35.53%
  • EBITDA margin-118.40%
  • EBITDA-$52.18M
  • EV$120.95M
  • EV/Revenue0.63
  • P/EN/A
  • P/S0.50
  • P/B0.96
Documents